Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Acute pain relief after Mantram meditation in children with neuroblastoma undergoing anti-GD2 monoclonal antibody therapy.

Ahmed M, Modak S, Sequeira S.

J Pediatr Hematol Oncol. 2014 Mar;36(2):152-5. doi: 10.1097/MPH.0000000000000024.

PMID:
24065045
[PubMed - indexed for MEDLINE]
2.

Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.

Parsons K, Bernhardt B, Strickland B.

Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5. Review.

PMID:
23386066
[PubMed - indexed for MEDLINE]
3.

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

Cheung NK, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA.

J Clin Oncol. 1987 Sep;5(9):1430-40.

PMID:
3625258
[PubMed - indexed for MEDLINE]
4.

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Kushner BH, Modak S, Basu EM, Roberts SS, Kramer K, Cheung NK.

Cancer. 2013 Aug 1;119(15):2789-95. doi: 10.1002/cncr.28137. Epub 2013 Apr 30.

PMID:
23633099
[PubMed - indexed for MEDLINE]
5.

Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

Kushner BH, Kramer K, Modak S, Cheung NK.

J Clin Oncol. 2011 Mar 20;29(9):1168-74. doi: 10.1200/JCO.2010.28.3317. Epub 2011 Feb 22.

PMID:
21343563
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

Cheung NK, Modak S.

Clin Cancer Res. 2002 May;8(5):1217-23.

PMID:
12006541
[PubMed - indexed for MEDLINE]
Free Article
7.

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.

Cheung NK, Cheung IY, Kushner BH, Ostrovnaya I, Chamberlain E, Kramer K, Modak S.

J Clin Oncol. 2012 Sep 10;30(26):3264-70. doi: 10.1200/JCO.2011.41.3807. Epub 2012 Aug 6.

PMID:
22869886
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.

Cheung NK, Kushner BH, Yeh SD, Larson SM.

Int J Oncol. 1998 Jun;12(6):1299-306.

PMID:
9592190
[PubMed - indexed for MEDLINE]
9.

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.

Cheung NK, Cheung IY, Canete A, Yeh SJ, Kushner B, Bonilla MA, Heller G, Larson SM.

Cancer Res. 1994 Apr 15;54(8):2228-33.

PMID:
8174131
[PubMed - indexed for MEDLINE]
Free Article
10.

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.

Kramer K, Gerald WL, Kushner BH, Larson SM, Hameed M, Cheung NK.

Med Pediatr Oncol. 2001 Jan;36(1):194-6.

PMID:
11464881
[PubMed - indexed for MEDLINE]
11.

Evidence-based nonpharmacologic interventions for pediatric pain: an editorial commentary.

Bingen K.

J Pediatr Hematol Oncol. 2014 Mar;36(2):150-1. doi: 10.1097/MPH.0000000000000075. No abstract available.

PMID:
24309608
[PubMed - indexed for MEDLINE]
12.

Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.

Navid F, Sondel PM, Barfield R, Shulkin BL, Kaufman RA, Allay JA, Gan J, Hutson P, Seo S, Kim K, Goldberg J, Hank JA, Billups CA, Wu J, Furman WL, McGregor LM, Otto M, Gillies SD, Handgretinger R, Santana VM.

J Clin Oncol. 2014 May 10;32(14):1445-52. doi: 10.1200/JCO.2013.50.4423. Epub 2014 Apr 7.

PMID:
24711551
[PubMed - indexed for MEDLINE]
13.

Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.

Cheung IY, Lo Piccolo MS, Collins N, Kushner BH, Cheung NK.

Cancer. 2002 Jun 1;94(11):3042-8.

PMID:
12115395
[PubMed - indexed for MEDLINE]
Free Article
14.

A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.

Ye JN, Cheung NK.

Int J Cancer. 1992 Jan 21;50(2):197-201.

PMID:
1730513
[PubMed - indexed for MEDLINE]
15.

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.

Kramer K, Gerald WL, Kushner BH, Larson SM, Hameed M, Cheung NK.

Clin Cancer Res. 1998 Sep;4(9):2135-9.

PMID:
9748131
[PubMed - indexed for MEDLINE]
Free Article
16.

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.

Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM.

Cancer. 1997 Jul 15;80(2):317-33.

PMID:
9217046
[PubMed - indexed for MEDLINE]
17.

Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma.

Simon T, Hero B, Faldum A, Handgretinger R, Schrappe M, Niethammer D, Berthold F.

J Clin Oncol. 2004 Sep 1;22(17):3549-57.

PMID:
15337804
[PubMed - indexed for MEDLINE]
Free Article
18.

High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.

Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.

Pediatr Blood Cancer. 2007 Apr;48(4):430-4.

PMID:
16421906
[PubMed - indexed for MEDLINE]
19.

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.

Cheung NK, Kushner BH, Cheung IY, Kramer K, Canete A, Gerald W, Bonilla MA, Finn R, Yeh SJ, Larson SM.

J Clin Oncol. 1998 Sep;16(9):3053-60.

PMID:
9738575
[PubMed - indexed for MEDLINE]
20.

Monoclonal antibodies and neuroblastoma.

Miraldi F.

Semin Nucl Med. 1989 Oct;19(4):282-94. Review.

PMID:
2678480
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk